Clinical Trials Browser

Phase 1 × OTHER_GOV × Thoracic × Clear all

Mesothelioma, Thymoma, Neuroendocrine Tumors

NCT07523464 2026-04-13

Centrally Confined 8Gy/1f to Tumor Core Followed by Concurrent Chemoradiotherapy for Unresectable Stage III NSCLC

Phase 1 Not yet recruiting

24 enrolled

Thoracic

Locally-Advanced Non-Small Cell Lung Cancer

NCT06232083 2025-07-09

A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR)

Phase 1 Recruiting

20 enrolled

GastrointestinalGynecologicThoracic

Uterine Cervical Neoplasms, Esophageal Neoplasms, Lung Neoplasms

NCT06760676 2025-01-07

A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate External Irradiation (PLDR) for Disease Progression After Previous Anti-tumor Therapy

Phase 1 Not yet recruiting

90 enrolled

GastrointestinalGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms

NCT02938624 2021-12-14

MK3475-223

Phase 1 Completed

28 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04142931 2021-03-24

Sequentional Immuno Apheresis Plasma Volume Escalation Cohort Study of Reduction of Soluble Tumor Necrosis Factor Receptors 1 and 2 (sTNFR1/2) With or Without Nivolumab in Patients With Inoperable or Metastatic Solid Tumors

Phase 1 Unknown

30 enrolled

BreastDermatologicGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Triple Negative Breast Neoplasms

NCT03790228 2020-04-15

Anlotinib Combined With Pemetrexed And Carboplatin as First-line Treatment in Advanced Nonsquamous NSCLC

Phase 1 Unknown

43 enrolled

Thoracic

Non-squamous Cell Non-Small Cell Lung Cancer

NCT02611245 2018-06-08

NIR Fluorescence Imaging Technique in Thoracic Surgery With ICG

Phase 1 Completed

36 enrolled

GastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms

Clinical Trials

LuPARP

Centrally Confined 8Gy/1f to Tumor Core Followed by Concurrent Chemoradiotherapy for Unresectable Stage III NSCLC

A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR)

A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate External Irradiation (PLDR) for Disease Progression After Previous Anti-tumor Therapy

MK3475-223

Sequentional Immuno Apheresis Plasma Volume Escalation Cohort Study of Reduction of Soluble Tumor Necrosis Factor Receptors 1 and 2 (sTNFR1/2) With or Without Nivolumab in Patients With Inoperable or Metastatic Solid Tumors

Anlotinib Combined With Pemetrexed And Carboplatin as First-line Treatment in Advanced Nonsquamous NSCLC

NIR Fluorescence Imaging Technique in Thoracic Surgery With ICG